BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Second Sight Release: Retinal Prosthesis Helps Blind Subjects Detect Motion


10/11/2012 10:11:07 AM

SYLMAR, Calif.--(BUSINESS WIRE)--A study recently published online, and set to be issued in the February print edition of the peer-reviewed journal, Archives of Ophthalmology, demonstrated that the Argus® II Retinal Prosthesis System (Argus II – Manufactured by Second Sight Medical Products Inc.) enabled a majority of blind participants, implanted with the device, to identify the direction of moving objects better with the Argus II on than off. This journal article is the latest in a series of publications that shows that the Argus II restores some visual function to patients blinded by retinitis pigmentosa (RP), and that this function translates into real benefits in everyday life. Last month, an FDA Ophthalmic Devices Advisory Panel voted unanimously that the probable benefit of the Argus II outweighs the risks to health, clearing the way for regulatory approval in the US. The Argus II system has been approved for use in the European Economic Area and is on the market in several European countries since last year and remains the only approved retinal implant anywhere in the world.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->